5-((4-((1,3-DIMETHYL-1H-INDAZOL-6-YL)METHYLAMINO)-2-PYRIMIDINYL)AMINO)-2-METHYLBENZENESULFONAMIDE
UNII LT2XRG56LG
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-((4-((1,3-dimethyl-1h-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methylbenzenesulfonamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LT2XRG56LG.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2369664-25-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H23N7O2S RYPDXEUOZLKYKE-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-((4-((1,3-dimethyl-1h-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methylbenzenesulfonamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.